世界のペプチドベース癌治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4497 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ペプチドベース癌治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゴセレリン、ボルテゾミブ、リュープロレリン、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ペプチドベース癌治療薬の市場動向 ・企業の競争状況、市場シェア ・ペプチドベース癌治療薬の種類別市場規模（ゴセレリン、ボルテゾミブ、リュープロレリン、その他） ・ペプチドベース癌治療薬の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局） ・ペプチドベース癌治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ペプチドベース癌治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ペプチドベース癌治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ペプチドベース癌治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ペプチドベース癌治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、AstraZeneca、Johnson & Johnson、Abbott Laboratories、Allergan、AbbVie、Bausch Health、Takeda Pharmaceutical） ・結論

Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.

Market Analysis and Insights: Global Peptide Based Cancer Therapeutics Market
The global Peptide Based Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peptide Based Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peptide Based Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peptide Based Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peptide Based Cancer Therapeutics market.

Global Peptide Based Cancer Therapeutics Scope and Market Size
Peptide Based Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Based Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Goserelin
Bortezomib
leuprorelin
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
AstraZeneca
Johnson & Johnson
Abbott Laboratories
Allergan
AbbVie
Bausch Health
Takeda Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Based Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Goserelin
1.2.3 Bortezomib
1.2.4 leuprorelin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Peptide Based Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peptide Based Cancer Therapeutics Market Perspective (2016-2027)
2.2 Peptide Based Cancer Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peptide Based Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Peptide Based Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Peptide Based Cancer Therapeutics Industry Dynamic
2.3.1 Peptide Based Cancer Therapeutics Market Trends
2.3.2 Peptide Based Cancer Therapeutics Market Drivers
2.3.3 Peptide Based Cancer Therapeutics Market Challenges
2.3.4 Peptide Based Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Cancer Therapeutics Players by Revenue
3.1.1 Global Top Peptide Based Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Peptide Based Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Peptide Based Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peptide Based Cancer Therapeutics Revenue
3.4 Global Peptide Based Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Peptide Based Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Based Cancer Therapeutics Revenue in 2020
3.5 Peptide Based Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Peptide Based Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Peptide Based Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Based Cancer Therapeutics Breakdown Data by Type
4.1 Global Peptide Based Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Peptide Based Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Peptide Based Cancer Therapeutics Breakdown Data by Application
5.1 Global Peptide Based Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Peptide Based Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peptide Based Cancer Therapeutics Market Size (2016-2027)
6.2 North America Peptide Based Cancer Therapeutics Market Size by Type
6.2.1 North America Peptide Based Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Peptide Based Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Peptide Based Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Peptide Based Cancer Therapeutics Market Size by Application
6.3.1 North America Peptide Based Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Peptide Based Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Peptide Based Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Peptide Based Cancer Therapeutics Market Size by Country
6.4.1 North America Peptide Based Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Peptide Based Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Peptide Based Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Peptide Based Cancer Therapeutics Market Size by Type
7.2.1 Europe Peptide Based Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Peptide Based Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Peptide Based Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Peptide Based Cancer Therapeutics Market Size by Application
7.3.1 Europe Peptide Based Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Peptide Based Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Peptide Based Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Peptide Based Cancer Therapeutics Market Size by Country
7.4.1 Europe Peptide Based Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Peptide Based Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peptide Based Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peptide Based Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Peptide Based Cancer Therapeutics Market Size by Type
9.2.1 Latin America Peptide Based Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Peptide Based Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Peptide Based Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Peptide Based Cancer Therapeutics Market Size by Application
9.3.1 Latin America Peptide Based Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Peptide Based Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Peptide Based Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Peptide Based Cancer Therapeutics Market Size by Country
9.4.1 Latin America Peptide Based Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Peptide Based Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peptide Based Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Peptide Based Cancer Therapeutics Introduction
11.1.4 Pfizer Revenue in Peptide Based Cancer Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Peptide Based Cancer Therapeutics Introduction
11.2.4 AstraZeneca Revenue in Peptide Based Cancer Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Peptide Based Cancer Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Peptide Based Cancer Therapeutics Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Peptide Based Cancer Therapeutics Introduction
11.4.4 Abbott Laboratories Revenue in Peptide Based Cancer Therapeutics Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Peptide Based Cancer Therapeutics Introduction
11.5.4 Allergan Revenue in Peptide Based Cancer Therapeutics Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Peptide Based Cancer Therapeutics Introduction
11.6.4 AbbVie Revenue in Peptide Based Cancer Therapeutics Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Bausch Health
11.7.1 Bausch Health Company Details
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Peptide Based Cancer Therapeutics Introduction
11.7.4 Bausch Health Revenue in Peptide Based Cancer Therapeutics Business (2016-2021)
11.7.5 Bausch Health Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Peptide Based Cancer Therapeutics Introduction
11.8.4 Takeda Pharmaceutical Revenue in Peptide Based Cancer Therapeutics Business (2016-2021)
11.8.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peptide Based Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Goserelin
Table 3. Key Players of Bortezomib
Table 4. Key Players of leuprorelin
Table 5. Key Players of Others
Table 6. Global Peptide Based Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peptide Based Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Peptide Based Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Peptide Based Cancer Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Peptide Based Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Peptide Based Cancer Therapeutics Market Share by Regions (2022-2027)
Table 12. Peptide Based Cancer Therapeutics Market Trends
Table 13. Peptide Based Cancer Therapeutics Market Drivers
Table 14. Peptide Based Cancer Therapeutics Market Challenges
Table 15. Peptide Based Cancer Therapeutics Market Restraints
Table 16. Global Peptide Based Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Peptide Based Cancer Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Peptide Based Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Cancer Therapeutics as of 2020)
Table 19. Ranking of Global Top Peptide Based Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Peptide Based Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Peptide Based Cancer Therapeutics Product Solution and Service
Table 23. Date of Enter into Peptide Based Cancer Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peptide Based Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Peptide Based Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Peptide Based Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Peptide Based Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Peptide Based Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Peptide Based Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Peptide Based Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Peptide Based Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Peptide Based Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Peptide Based Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Peptide Based Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Peptide Based Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Peptide Based Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Peptide Based Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Peptide Based Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Peptide Based Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Peptide Based Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Peptide Based Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Peptide Based Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Peptide Based Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Peptide Based Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Peptide Based Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Peptide Based Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Peptide Based Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Peptide Based Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Peptide Based Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Peptide Based Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Peptide Based Cancer Therapeutics Product
Table 66. Pfizer Revenue in Peptide Based Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Peptide Based Cancer Therapeutics Product
Table 71. AstraZeneca Revenue in Peptide Based Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Peptide Based Cancer Therapeutics Product
Table 76. Johnson & Johnson Revenue in Peptide Based Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Peptide Based Cancer Therapeutics Product
Table 81. Abbott Laboratories Revenue in Peptide Based Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Abbott Laboratories Recent Development
Table 83. Allergan Company Details
Table 84. Allergan Business Overview
Table 85. Allergan Peptide Based Cancer Therapeutics Product
Table 86. Allergan Revenue in Peptide Based Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Allergan Recent Development
Table 88. AbbVie Company Details
Table 89. AbbVie Business Overview
Table 90. AbbVie Peptide Based Cancer Therapeutics Product
Table 91. AbbVie Revenue in Peptide Based Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 92. AbbVie Recent Development
Table 93. Bausch Health Company Details
Table 94. Bausch Health Business Overview
Table 95. Bausch Health Peptide Based Cancer Therapeutics Product
Table 96. Bausch Health Revenue in Peptide Based Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Bausch Health Recent Development
Table 98. Takeda Pharmaceutical Company Details
Table 99. Takeda Pharmaceutical Business Overview
Table 100. Takeda Pharmaceutical Revenue in Peptide Based Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Takeda Pharmaceutical Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Based Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Goserelin Features
Figure 3. Bortezomib Features
Figure 4. leuprorelin Features
Figure 5. Others Features
Figure 6. Global Peptide Based Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Peptide Based Cancer Therapeutics Report Years Considered
Figure 11. Global Peptide Based Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Peptide Based Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Peptide Based Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Peptide Based Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Peptide Based Cancer Therapeutics Market Share by Players in 2020
Figure 16. Global Top Peptide Based Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Cancer Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Peptide Based Cancer Therapeutics Revenue in 2020
Figure 18. Global Peptide Based Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Peptide Based Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Peptide Based Cancer Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Peptide Based Cancer Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Peptide Based Cancer Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peptide Based Cancer Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Peptide Based Cancer Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Peptide Based Cancer Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peptide Based Cancer Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Peptide Based Cancer Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Peptide Based Cancer Therapeutics Market Share by Region (2016-2027)
Figure 40. China Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peptide Based Cancer Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Peptide Based Cancer Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Peptide Based Cancer Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peptide Based Cancer Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Peptide Based Cancer Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Peptide Based Cancer Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Peptide Based Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2016-2021)
Figure 62. Abbott Laboratories Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2016-2021)
Figure 64. AbbVie Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2016-2021)
Figure 65. Bausch Health Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2016-2021)
Figure 66. Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Cancer Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---